Can drugs stop paedophiles from committing crime?

Image
IANS London
Last Updated : May 09 2016 | 5:14 PM IST

With a view to reducing the risk of child sexual abuse, Swedish researchers are planning to examine the effectiveness of a drug to prevent paedophiles from committing crime.

In a unique trial, The Karolinska Institute in Stockholm is using a testosterone-suppressing drug as a preventative measure on patients seeking help for paedophile fantasies, The Independent reported.

Patients at the Karolinska Institute who have had paedophilic fantasies but have not acted on them are being given a drug normally used to treat advanced prostate cancer to see if it reduces the risk of them sexually abusing a child.

Christoffer Rahm is the initiator and the principal investigator of this treatment study.

"This project aims to reduce the number of child sexual abuse cases. In order to achieve this we are exploring one of the few feasible strategies, to establish a preventive, effective and risk reducing treatment for men with paedophilic disorder that is also tolerable for the patient," the researchers wrote on the British science crowdfunding platform Walacea for raising a portion of the research fund.

"In addition to providing better treatment options to patients with paedophilic disorder we aim to introduce a reliable objective risk assessment tool. We want to shift focus from what happens when the damage is already done, and instead focusing on the earlier phase, to intervene before the child sexual abuse happens in the first place," they added.

This crowdfunding campaign that closes on July 7, 2016 plans to raise funds for the first part of this project, the clinical trial to test the effectiveness of the drug degarelix.

In this trial of 60 patients, 30 receive an injection of the drug Degarelix and the other 30 are given a placebo.

Trial volunteers will be studied for the next two to three years, the report added.

--IANS

gb/dg

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: May 09 2016 | 5:04 PM IST

Next Story